Mr. Richard Swedlow, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 E Park Ave, Long Beach, NY 11561 Phone: 516-889-6704 |
Mr. Tom Janus Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 310 W Park Ave, Long Beach, NY 11561 Phone: 516-897-4052 Fax: 516-897-0828 |
Jordana Cohen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Flroa Plesser Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Park Pl, Long Beach, NY 11561 Phone: 917-501-3212 |
Ms. Dulari Sameer Sutaria, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Park Pl, Long Beach, NY 11561 Phone: 516-889-8770 |
Dr. Motria Maria Mishko, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Mrs. Jane Kozlovsky, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Mr. Thomas M Honan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Miriam Ilyaich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Mr. Carl Snetkin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Park Pl # 790, Long Beach, NY 11561 Phone: 516-536-0800 |
Dr. Roger Er-mu Kuo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Mrs. Paula Agoglia, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Park Pl, Long Beach, NY 11561 Phone: 516-889-8770 |
Yupeng Nan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Andrea Markoulli Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Mr. Kenneth L. Pollack Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23 E Park Ave, Long Beach, NY 11561 Phone: 516-431-4422 |
Mr. Stephen B Pearlstein, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Place, Long Beach, NY 11561 Phone: 516-536-0800 |
Mr. Andrew Jeff Howard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
Mr. Mark A Brodsky, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Place, Long Beach, NY 11561 Phone: 516-536-0800 |
Mr. Ruslan Urman, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 Park Pl, Long Beach, NY 11561 Phone: 516-889-8225 |
Lisa Ann Mann, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Park Pl, Long Beach, NY 11561 Phone: 516-536-0800 |
News Archive
The Christopher & Dana Reeve Foundation, a leading nonprofit dedicated to improving quality of life for individuals living with paralysis, announced it has awarded $600,137 in Quality of Life grants to 75 nonprofit organizations nationwide.
During surgical removal of thyroid tissue suspicious for cancer, fast, reliable, and cost-effective techniques are needed to analyze the resected tissue for biomarkers—including BRAF V600E, is a molecular biomarker for papillary thyroid cancer (PTC)—that can confirm the presence and type of cancer cells. Researchers have developed a new, rapid method for direct detection of the BRAF V600E gene in thyroid tissue without the need to purify DNA from tumor cells—high resolution melting analysis.
OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact. Last year, the Company hired a Director of Sales based in Wales. Recently, a full-market UK release of the AcceleDent System was reported. In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.
According to a new study published in The Oncologist, patients with advanced cancer who are diagnosed with delirium when turning up in emergency departments are more likely to be admitted to hospital and more likely to die earlier than patients without delirium.
Actavis, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone.
› Verified 2 days ago